This site is intended for U.S. Healthcare Professionals only.

U.S. Full Prescribing Information, including Boxed WARNING


CAMZYOS® Select Safety Profile1


Based on the safety profile from the pivotal EXPLORER-HCM trial, there were no new adverse reactions identified in VALOR-HCM1

See EXPLORER-HCM safety >

This website is best viewed
using the horizontal display
on your tablet device.

This website is best viewed
using the vertical display
on your mobile device.


  1. CAMZYOS [package insert]. Princeton, NJ: Bristol-Myers Squibb Company; 2023.
3500-US-2300530 07/23